Eagle Pharmaceuticals Inc logo

Eagle Pharmaceuticals Inc

$ 26.93 +1.95 (+7.81%) 12:36 PM EST
P/E:
15.31
P/B:
1.50
Market Cap:
$ 358.29M
Enterprise V:
$ 352.33M
Volume:
44.16K
Avg Vol (2M):
190.14K
Also Trade In:
Volume:
44.16K
Market Cap $:
358.29M
PE Ratio:
15.31
Avg Vol (2-Month):
190.14K
Enterprise Value $:
352.33M
PB Ratio:
1.50
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.
Name Current Vs Industry Vs History
Cash-To-Debt 0.68
Equity-to-Asset 0.62
Debt-to-Equity 0.23
Debt-to-EBITDA 1.15
Interest Coverage 33.79
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.14
Distress
Grey
Safe
Beneish M-Score -1.76
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 21.66
9-Day RSI 24.2
14-Day RSI 25.45
6-1 Month Momentum % -37.14
12-1 Month Momentum % -43.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.78
Quick Ratio 1.25
Cash Ratio 0.34
Days Inventory 123.76
Days Sales Outstanding 95.93
Days Payable 75.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 2.8

Financials (Next Earnings Date:2022-11-09 Est.)

EGRX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:EGRX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 272.183
EPS (TTM) ($) 1.76
Beta 0.38
Volatility % 30.88
14-Day RSI 25.45
14-Day ATR ($) 1.501515
20-Day SMA ($) 28.8265
12-1 Month Momentum % -43.34
52-Week Range ($) 24.35 - 58.25
Shares Outstanding (Mil) 13.28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Eagle Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Eagle Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.